Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Vectorious Medical; Respicardia
- Salary/Salary Support/Employee (Personal) - V-WaveMedical
- Equity/Stock(s)/Options (Personal) - Cardionomic; scPharma